SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AQUILA BIOPHARMACEUTICALS INC (AQLA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harry J. who wrote (14)2/23/2000 11:00:00 AM
From: Harry J.  Read Replies (2) of 45
 
AQLA mentioned in today's WSJournal at p. C9. *Small Stock Focus* notes it "sank" 1 13/16 and reported a 4th qtr loss of 24 cents vs. a year-ago profit of 14 cents on revenue down 63% from a year earlier. The PRNewswire for yesterday (22 Feb) under "News" below says the 1999 4th qtr loss was 25 cents vs. a year-ago *loss* of 14 cents. I think the WSJournal got it wrong. The PR has some additional annualized information on the effect of the VacTex acquisition costs and on some payments received in 2000. Of course, it also contains the 3 mos.-ended and yr.-ended balance sheets.

Regards,
Harry J.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext